Instruction to Authors

The Journal of Pharmaceutical is a online Journal as well as Hard Print, which publishes original research work that contributes significantly to further the scientific knowledge in Pharmaceutical Sciences (Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Pharmacology, Pharmaceutical Analysis, Regulatory Affair, Pharmacy Practice, Clinical and Hospital Pharmacy, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest). The Journal publishes original research work either as a Full Research Paper or as a Short Communication and Review Articles on a current topic in Pharmaceutical Sciences is also considered for publication by the Journal.

To maintain the high standards of editorial in journal, articles are only published if they pass Editorial Process:
  1. Are not promotional in any way, including relating to a product(s) and/or a company (ies), are new, timely and relevant to the pharmaceutical manufacturing industry.
  2. For submitted manuscripts, it is the responsibility of the author(s) to demonstrate novelty or a new approach taken in his research. The references should reflect the most recent relevant articles, and the discussion should compare the author’s findings with the results of former investigations. For an experimental work, the data have to be determined and classified in a suitable way, problems must be formulated in view of the data, hypotheses should be suggested an/or the author should give possible explanations for any inconsistencies.
    If possible, the author(s) should perform mathematical or statistical calculations, fit the curves appropriate, and carry out the experiments under controlled conditions. Studies involving animals or human volunteers must include details of ethical approval.
  3. Authors are requested to submit all manuscripts online along with cover page, manuscripts strictly to only. Manuscripts submitted to other email will not be considered for publications.
    Paper copy submissions are no longer acceptable. Articles are considered for publication depending on their value and pharmaceutical relevance and with the understanding that they have not been published previously and are submitted exclusively to the journal. All manuscripts are subject to experts review. Additional corrections may be done by the editors.
  4. A PDF-file of the article is delivered free of charge after the paper has been published in the journal. Please note that, by copyright reasons, this is for personal use of the authors only and must not be made available, e.g. by posting on a freely accessible website.
  5. Submission of a manuscript to Journal of Pharmaceutical for publication implies that the same work has not been either published or under consideration for publication in another Journal. The research paper will passed a blind peer review by a member of the Journal of Pharmaceutical’s Editorial Advisory Board or an expert in the field nominated by the Editorial Advisory Board.
Keywords Please provide a list of keywords relevant to the article, as well as websites or additional online references and materials that might be of interest to readers. Please include mention of such items, if applicable and available, when you submit your paper.
  1. Title - Title should contain title of the paper in bold face, title case (font size 14), names of the authors in normal face, upper case (font size 12) followed by the address(es) in normal face lower case. The author to whom all correspondence be addressed should be denoted by an asterisk mark. The title should be as short as possible and precisely indicate the nature of the work in the communication. Names of the authors should appear as initials followed by surnames for men and one given-name followed by surname for women. Full names may be given in some instances to avoid confusion. Names should not be prefixed or suffixed by titles or degrees. Names should be followed by the complete postal address or addresses with pin code numbers of the place(s), where the research work has been carried out. At the bottom left corner of the title page, please mention “*Address For correspondence” and provide a functional e-mail address. Address of the corresponding author to whom all correspondence may be sent should be given only if it is different from the address already given under authors’ names. Title page should be aligned centre except for “*Address For correspondence”.
    Provide a running title or short title of not more than 50 characters.
  2. Each manuscript should start with an abstract, containing the most essential results of the study. Extensive review papers and articles for continuous education should be preceded by an outline of topics. Papers should be subdivided into chapters and subchapters according to the decimal system (e.g. 2.1.3.).
  3. To achieve clarity and brevity of the presentation, original contributions should be subdivided after the abstract (see 2.) as follows:


    This should indicate the question under investigation which is generally based on a brief interpretation of the literature considering the current state of knowledge in the subfield and explaining the necessary theoretical foundations. The Introduction should lead the reader to the importance of the study; tie-up published literature with the aims of the study and clearly states the rationale behind the investigation.

    All important materials used along with their source shall be mentioned. The main methods used shall be briefly described, citing references. Trivial details may be avoided. New methods or substantially modified methods may be described in sufficient detail. The statistical method and the level of significance chosen shall be clearly stated. This part describes briefly the detailed experimental conditions. Unless directions taken from literature have been modified, it suffices to refer to the original source. All images, figures, graphs, and tables must be at the end of the article

    The number of figures and tables should not exceed 6 in total.

    All findings presented in tabular or graphical form shall be described in this section. The data should be statistically analyzed and the level of significance stated. Data that is not statistically significant need only to be mentioned in the text - no illustration is necessary. All Tables and figures must have a title or caption and a legend to make them self-explanatory.

    This section should deal with the interpretation of results, convey how they help increase current understanding of the problem and should be logical. Unsupported hypothesis should be avoided. There is no need to include another title such as “Conclusions” at the end of Result and Discussion.

    Literature citations in the text should be numbered consecutively and indicated by Arabic numerals in parentheses after appropriate sentences and/or paragraphs. Please do not use endnotes or footnotes. References should be grouped at the end of the manuscript and arranged in order of their appearance in the text not alphabetically.

Please adhere to our reference style below, which may be further edited by the Journal of Pharmaceutical staff

  • Chapter in a book: E.F. Fiese and T.A. Hagen, “Preformulation,” in Theory and Practice of Industrial Pharmacy, L. Lachman, H.A. Lieberman, and J.L. Kanig, Eds. (Lea & Febiger, Philadelphia, PA, 3rd ed., 1986), pp. 171–194.
  • Article in a Journal: G.M. Golden, J.E. McKie, and R.O. Potts, “Role of Stratum Corneum Lipid Fluidity in Transdermal Drug Flux,” J. Pharm. Sci. 76 (1), 25–28 (1987).
  • Published Conference Proceedings: J.B. Dressman, “Predicting Release Kinetics from Enteric-Coated Dosage Forms,” in Proceedings of Pharm Tech Conference (Aster Publishing Corporation, Eugene, OR, 1988), pp. 239–250.
  • Oral presentations: B.L. Hawkins, A. Baxter, and G.E. Masters, “NMR Preview: A Look to the 1990s,” presented at the 25th Experimental NMR Conference, Wilmington, DE, Feb. 1984 J. Woodcock, MD, Statement, House Committee on Energy and Commerce Hearing, Apr. 29,2008, available at, accessed May 8, 2008
  • Government publications: Code of Federal Regulations, Title 21, Food and Drugs (Government Printing Office, Washington, DC), Part 121, pp. 270–290. “Potable Water, Control of Communicable Diseases,” in Code of Federal Regulations, Title 21, Food and Drugs (Government Printing Office, Washington, DC), Part 1240.3 (m), pp. X–X. (Note: same style as chapter in a book, but without an author). FDA, “Human and Veterinary Drugs, Good Manufacturing Practices and Proposed Exemptions for Certain OTC Products,” Fed.Regist. 43 (190), 45013–45089 (Sept. 29, 1978). “Minimizing the Risk of Transmitting Animal Spongiform Encephalopathy Agents Via Medicinal Products,” in European Pharmacopoeia (European Directorate for the Quality of Medicines, Strasbourg, France, YEAR), General Text 5.2.8, pp–pp. ICH and FDA, Q1B Photo stability testing of New Drug Substances and Products (Geneva, Switzerland, and Rockville, MD, Nov. 1996),, accessed Sept. 15, 2005. Photo stability Testing of New Drug Substances and Products (Geneva, Switzerland, and Rockville, MD, Nov. 1996), available at fda. gov/cder/guidance/1318.htm, accessed Sept. 15, 2005. (Note: same as book style, add web url only if entire document is online, update access date). FDA, Guidance Title (Rockville, MD, Nov. 2004). [Note: Add a URL if entire document is available online.]
  • USP publications: USP 27–NF 22 (US Pharmacopeial Convention, Rockville, MD, 2003), pp. X–X.
    [Note: If the above is a reference for an entire General Chapter or other titled section in USP, then it follows the style of a book chapter]
    USP Proposed General Test <429>, “Light Diffraction Measurement of Particle Size,” Pharmacopeial Forum 28 (4), 1293–1298. Patents Author or Company name, “Transmitter Switch for Wireless ID,” US patent 125356, Dec. 2003.

Limitations for Papers Submitted Under Each Category

Article type Abstract: No. of words Key words: No. of words Running title No. of characters Tables/Figures Number of references
Review Article < 250 3-6 < 50 Max. total of Five < 100
Research Article < 250 3-7 < 50 Max. total of Eight < 25
Short Communication NR NR < 50 Max total of Three < 10

NR = Not Required
  • Tables: All tables must be numbered consecutively (using Arabic numerals) and be cited in the text. Titles should be short but descriptive. Each table should be on a separate sheet, together with a legend and/or footnotes identified by superscripts a, b, c, etc. In tables, the units are usually in brackets following the quantity, and the font should be Times New Roman and size of 12 pt.
  • Figures: Figures (photographs, drawing, diagrams and charts) are to be numbered in one consecutive series of Arabic numerals in the order in which they are cited in the text and abbreviated as Figure X. The captions for figures should be typed on a separate sheet of paper.
  • Formula and equations: Structural and chemical formula, process flow diagrams and complicated mathematical expressions should be very clearly presented. All subscripts, Greek letters and unusual characters must be identified. Structural and chemical formulae as well as process flow diagrams should be prepared in the same way as graphs.
  • Review articles: Review articles should be about 15 journal pages and contain up-to-date information providing comprehensive coverage of relevant literature. Review articles should preferably be written by scientists who have in-depth knowledge of the topic. All format requirements are similar to those applicable to Research papers. Review Articles need not be divided into sections such as Materials and methods, and Results and discussion, but should definitely have an abstract and introduction.

Rapid Communication

Proofreading and Publication Charges

Proof reading is not re-writing. Checking the proofs is solely the authors' responsibility. Corrections are restricted to printing errors. Answer all queries (in the interest of accuracy) on the proof. Make all corrections legibly (preferably by typing) in the margins, or point out the mistakes in another separate file.

After acceptance of your manuscript author/authors has/have to pay INR Rs. 500/- per manuscript and for foreign manuscript author/authors has/have to pay US $ 20/- per manuscript. No hard copy will be provided to author and co-authors, only soft copy will be available. If authors / co-authors wish print copy will be available on additional payment of Rs. 500/- per copy.

Copyright Transfer Agreement


All manuscripts must be submitted through the online. Author must have to provide names of three qualified reviewers who have had maximum experience in the subject of the submitted article, but who are non-affiliated with the same institute. However, selection of the reviewers is the sole discretion of the editor.